Nixon Vanderhye’s Biotechnology team understands the issues faced by innovators in the biotechnology, life sciences, pharmaceuticals, and medical devices industries. Our team is purpose-built of seasoned IP attorneys with a unique blend of advanced technical knowledge and industry experience that is united by a strong commitment to deliver dedicated, efficient and effective intellectual property strategic counseling and services tailored to meet the particular needs of our clients.
All members of the team have at least 10 years of experience prosecuting patents before the U.S. Patent and Trademark Office (USPTO) and globally. Most attorneys have Ph.D.-level technical training in chemistry, biology, genetics, or a closely related field. The team includes attorneys who have served as in-house legal counsel and lead drug discovery scientists for major biotechnology and pharmaceutical companies, and those who have held positions at federal agencies, including at the USPTO and the U.S. Department of Justice.
Our team helps with strategic IP portfolio planning, development, acquisition, and enforcement; all aspects of the patent process, including but not limited to patent preparation and prosecution both domestically and worldwide; patent landscape analyses; freedom to operate, patentability, non-infringement, and invalidity opinions; appeals; post-grant proceedings; reexaminations; and reissues. We provide strategic counseling on maximizing patent term and exclusivity, on IP due diligence, research collaborations, joint ventures, licensing and technology transfer, and IP audits.
RANGE OF TECHNOLOGIES
We work with a broad range of technologies at all stages of the drug product life cycle, from discovery through clinical development and commercialization. Our team represents biotechnology and life sciences companies at all stages, from formation to exit, across a broad range of technologies, including:
Therapeutic
Therapy
Protein Based Therapeutics
Biotherapeutics (Biologics and Biosimilars)
Antibody Based Drugs
Antibody Mimetics
Peptide Drugs
Vaccines
Nucleic Acid Based Therapeutics
RNA and RNA Analogue Therapeutics
DNA and DNA Analogue Therapeutics
Gene Therapy
Genome Editing
Cell Based Therapeutics
Tissue Engineering and Regeneration
Cell Engineering
Immune Therapeutics
Microbiome Based Therapeutics
Stem Cell, Progenitor, and Primary Cell Therapeutics
Regenerative Therapeutics
Targeted Therapeutics
Drug Discovery, Delivery, and Formulation Platforms
Manufacturing
Upstream Bioprocessing (Cell Culture, Bioreactor and Fermentation Technology)
Downstream Bioprocessing (Purification)
Formulation
Diagnostics
Protein Based Diagnostics Technologies
Nucleic Acid Based Diagnostics
Precision Medicine
Theranostics
Pharmacogenomics
Companion Diagnostics
Medical Devices
Industrial and Agricultural Biotechnology
Synthetic Biology
Protein Engineering
Biocatalysts (Enzymes and Microorganisms)
Bioprocessing (Bioreactor and Fermentation Technology)
Plant and Microorganism Metabolic Engineering
Genetically Modified Organisms (Microorganisms, Plants, and Animals)
Bio Based Products (Chemicals, Monomers, Polymers, and Gasses)
